Recruiting

A Study of LY3471851 in Participants With Eczema

J1P-MC-KFAD - ClinicalTrials.gov - NCT04081350

The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with eczema.
How long will I be in the trial?
The study will last up to 48 weeks and may include up to 23 visits to the study center.
Email
Recruiting

A Study of LY3471851 in Participants With Eczema

J1P-MC-KFAD - ClinicalTrials.gov - NCT04081350

The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with eczema.
How long will I be in the trial?
The study will last up to 48 weeks and may include up to 23 visits to the study center.
Email

Key Requirements

Age :

18-70

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-70

Sex

All

Participants must

Participants must have been diagnosed with eczema for at least 12 months

Participants must have active areas of eczema

Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)

Participants must NOT

Participants must not have received certain medications that were applied to the skin for eczema within 14 days prior to baseline (Day 1)

Participants must not have received certain oral or injectable medications or light therapy for eczema within 4 weeks prior to baseline

Participants must not have taken the study drug previously

Trial Summary

Conditions the trial is for

Atopic Dermatitis (Eczema)

What the trial is testing?

LY3471851, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

40

Trial Dates

December 2019 - September 2022

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-70

Sex

All

Participants must

Participants must have been diagnosed with eczema for at least 12 months

Participants must have active areas of eczema

Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)

Participants must NOT

Participants must not have received certain medications that were applied to the skin for eczema within 14 days prior to baseline (Day 1)

Participants must not have received certain oral or injectable medications or light therapy for eczema within 4 weeks prior to baseline

Participants must not have taken the study drug previously

Trial Summary

Conditions the trial is for

Atopic Dermatitis (Eczema)

What the trial is testing?

LY3471851, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

40

Trial Dates

December 2019 - September 2022

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Atopic Dermatitis (Eczema) Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?